aniracetam has been researched along with Cerebral Infarction, Middle Cerebral Artery in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sharma, H | 1 |
| Reeta, KH | 1 |
| Sharma, U | 1 |
| Suri, V | 1 |
| Singh, S | 1 |
| Sekiguchi, M | 1 |
| Yamada, K | 1 |
| Jin, J | 1 |
| Hachitanda, M | 1 |
| Murata, Y | 1 |
| Namura, S | 1 |
| Kamichi, S | 1 |
| Kimura, I | 1 |
| Wada, K | 1 |
2 other studies available for aniracetam and Cerebral Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
AMPA receptor modulation through sequential treatment with perampanel and aniracetam mitigates post-stroke damage in experimental model of ischemic stroke.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anti-Inflammatory Agents; Infarct | 2023 |
The AMPA receptor allosteric potentiator PEPA ameliorates post-ischemic memory impairment.
Topics: Allosteric Regulation; Animals; Brain; Brain Ischemia; Dose-Response Relationship, Drug; Excitatory | 2001 |